Clinical Trial Update: Preimplantation Genetic Diagnosis (PGD) by Array Comparative Genome Hybridization (CGH) and Blastocyst Biopsy [Phase 3]

View source ↗

Summary

Phase 3 trial of preimplantation genetic diagnosis by array CGH and blastocyst biopsy for infertility and miscarriage was terminated early.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Spontaneous Abortion

Snippet

Sponsor: Reprogenetics | Conditions: Infertility, Miscarriage | Phase 3 | Status: TERMINATED